Clinical consequences and longitudinal outcomes in PiMZ heterozygous a1-antitrypsin deficiency smokers from SPIROMICS

EUROPEAN RESPIRATORY JOURNAL(2021)

引用 0|浏览13
暂无评分
摘要
Background: The consequence of PiZ allele presence on lung function and emphysema in smokers from the SPIROMICS cohort were previously reported. The risk for accelerated lung function decline in heterozygous α-1 antitrypsin deficient smokers remains unclear. Focused on PiMZ heterozygosity as the most prevalent Z allele-containing genotype, we investigated its effects on baseline and longitudinal disease severity and progression. Methods: We identified 82 PiMZ and 2454 PiMM smokers without additional pathogenic SERPINA1 variation based on DNA sequencing. Baseline and longitudinal regression-based models included age, race, sex, smoking status and smoking history. Results: Compared to PiMM, PiMZ cohort was similar in age, sex, BMI, history of asthma and smoking, predominantly non-Hispanic white. PiMZ smokers had lower mean %predicted FEV1 (74.1±1.4 vs 65.9±3.1, p = 0.004) and were more likely to have emphysema based on normative equations for -950HU cutoff (OR 1.75, p=0.018). PiMZ smokers had a greater extent of parametric response mapping (PRM) emphysema (+3.4%, CI 0.4-6.3, p=0.027) but no significant difference in PRM functional small airway disease (+2.5%, CI -1.0-6.0, p=0.16) . In longitudinal models, there was a non-significant trend toward higher rate of severe exacerbations (SE) (RR=1.6, p=0.1), but no difference in mortality, the slope of FEV1 decline or SGRQ change over three years. Conclusion: Compared with PiMM genotype, smokers with PiMZ are more likely to have emphysema and with a trend towards more SE. Longer observational cohorts of PiMZ smokers are needed to characterize the natural history of lung disease in PiMZ heterozygotes.
更多
查看译文
关键词
COPD, Genetics, Orphan diseases
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要